Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
The pheochromocytomas are an important cause of secondary hypertension. Although pheochromocytoma susceptibility may be associated with germline mutations in the tumor-suppressor genes VHL and NF1 and in the proto-oncogene RET, the genetic basis for most cases of nonsyndromic familial pheochromocytoma is unknown. Recently, pheochromocytoma susceptibility has been associated with germline SDHD mutations. Germline SDHD mutations were originally described in hereditary paraganglioma, a dominantly inherited disorder characterized by vascular tumors in the head and the neck, most frequently at the carotid bifurcation. The gene products of two components of succinate dehydrogenase, SDHC and SDHD, anchor the gene products of two other components, SDHA and SDHB, which form the catalytic core, to the inner-mitochondrial membrane. Although mutations in SDHC and in SDHD may cause hereditary paraganglioma, germline SDHA mutations are associated with juvenile encephalopathy, and the phenotypic consequences of SDHB mutations have not been defined. To investigate the genetic causes of pheochromocytoma, we analyzed SDHB and SDHC, in familial and in sporadic cases. Inactivating SDHB mutations were detected in two of the five kindreds with familial pheochromocytoma, two of the three kindreds with pheochromocytoma and paraganglioma susceptibility, and 1 of the 24 cases of sporadic pheochromocytoma. These findings extend the link between mitochondrial dysfunction and tumorigenesis and suggest that germline SDHB mutations are an important cause of pheochromocytoma susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“germline mutations in the B, C and D subunits of SDH predispose individuals to hereditary paragangliomatosis with phaeochromocytomas (HPGL) (2 -6)”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, a biallelic loss of succinate dehydrogenase (SDH), an alteration found in familial paragangliomas and pheochromocytomas, as well as in a subset of sporadic gastrointestinal stromal tumors, creates a build-up of succinate (Astuti et al., 2001; Janeway et al., 2011).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Astuti et al., 2001
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The results of a clinical study further confirmed this observation by showing that patients with nonmetastatic lung cancer harbored loss-of-function mutations in SDH5128.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
Experimental — accuracy not yet measuredIn the citing paper
“In cancer cells, mutations in succinate dehydrogenase subunit B (SDHB) cause susceptibility to familial pheochromocytoma99 and familial paraganglioma100 as well as gastrointestinal stromal tumors101.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [99]
In the citing paper
“In addition to the tumorigenic effects of succinate accumulation, SDH5 mutation is the key driver supporting the acquisition of epithelial–mesenchymal transition (EMT) characteristics.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [128]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 3×
“…the iron-sulfur–protein subunit) and in both SDHC and SDHD (i.e., the genes for the integral membrane–protein subunits) are associated with neoplasia (Baysal et al. 2000; Niemann and Muller 2000; present study), autosomal recessive homozygous SDHA (i.e., the gene for the flavoprotein subunit)…”
BackgroundOhh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577 · cited 2×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundCockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050 · cited 1×
“…cancers and in mouse models, results in up-regulation of angiogenic growth factors, such as vascular endothelial growth factor, secondary to a defect in ubiquitylation of the a-subunits of the HIF-1 and the HIF-2 transcription factors (Maxwell et al. 1999; Cockman et al. 2000; Ohh et al. 2000).”
BackgroundSelf-citationMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875 · cited 4×
“…herein: PGL1 (MIM 168000), which results from SDHD mutations at 11q23; PGL2 (MIM 601650), which maps to 11q13, although the causative gene has not been identified (Mariman et al. 1995); and PGL3 (MIM 605373), which results from SDHC mutations at 1q21 (Baysal et al. 2000; Niemann and Muller 2000).”
BackgroundInfluentialBourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A. (1995) · Nature Genetics · doi:10.1038/ng1095-144 · Cited by 730 · cited 2×
“SDHA mutations are associated with juvenile encephalopathy (Bourgeron et al. 1995), and the phenotypic consequences of SDHB mutations have not been defined.”
BackgroundHoffman, M. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1019 · Cited by 382 · cited 1×
“Interestingly, germline VHL mutations that predispose patients to pheochromocytoma do not impair HIF-1a ubiquitylation (Clifford et al. 2001; Hoffman et al. 2001).”
BackgroundClifford, S. C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1029 · Cited by 373
Gimm, O., Armanios, M. Y., Dziema, H., Neumann, H. P. H., & Eng, C. (2000) · PubMed · Cited by 274
Self-citation
Cited by
Items 501–600 of 999
Bayley, J., Bausch, B., Rijken, J. A., van Hulsteijn, L. T., Jansen, J. C., Ascher, D. B., Pires, D. E. V., Hes, F. J., Hensen, E. F., Corssmit, E. P. M., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106214 · Cited by 33
Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
Zhao, Y., Feng, F., Guo, Q., Wang, Y., & Zhao, R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i34.5074 · Cited by 53
How many pathways to pheochromocytoma?
Neumann, H. P. H., Hoegerle, S., Manz, T., BRENNER, K. R., & Iliopoulos, O. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.30207 · Cited by 37
Mitochondrial Diseases ‐ An Expanding Spectrum of Disorders and Affected Genes
von Kleist-Retzow, J., Schauseil-Zipf, U., Michalk, D. V., & Kunz, W. S. (2003) · Experimental Physiology · doi:10.1113/eph8802509 · Cited by 32
Jugulotympanic paragangliomas: 75 years of evolution in understanding
Forbes, J. A., Brock, A. A., Ghiassi, M., Thompson, R. C., Haynes, D. S., & Tsai, B. S. (2012) · Neurosurgical FOCUS · doi:10.3171/2012.6.focus12138 · Cited by 29
Rapizzi, E., Ercolino, T., Fucci, R., Zampetti, B., Felici, R., Guasti, D., Morandi, A., Giannoni, E., Giaché, V., Bani, D., et al. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0172-3 · Cited by 32
“These genes include those encoding the four subunits of the succinate dehydrogenase (SDHA, SDHB, SDHC and SDHD) [4–7] and SDHAF2, which is responsible for the flavination of the SDHA subunit [8].”
BackgroundModels of parent-of-origin tumorigenesis in hereditary paraganglioma
Hoekstra, A. S., Devilee, P., & Bayley, J. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.05.011 · Cited by 35
Pęczkowska, M., Erlic, Z., Hoffmann, M. M., Furmanek, M. I., Ćwikła, J. B., Kubaszek, A., Prejbisz, A., Szutkowski, Z., Kawecki, A., Chojnowski, K., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1290 · Cited by 32
Self-citationGenetic Testing in Pheochromocytoma‐ and Paraganglioma‐Associated Syndromes
Benn, D. E., Richardson, A. L., Marsh, D. J., & Robinson, B. G. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.011 · Cited by 36
Maternal Transmission of Symptomatic Disease withSDHDMutation: Fact or Fiction?
Neumann, H. P. H., & Erlic, Z. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0569 · Cited by 31
Wilms Tumor in a Child with L-2-hydroxyglutaric Aciduria
Rogers, R. E., DeBerardinis, R. J., Klesse, L. J., Boriack, R. L., Margraf, L. R., & Rakheja, D. (2010) · Pediatric and Developmental Pathology · doi:10.2350/09-12-0768-cr.1 · Cited by 29
Shen, T., Wang, H., Tang, B., Zhu, G., & Wang, X. (2023) · RNA Biology · doi:10.1080/15476286.2023.2216562 · Cited by 31
Management of metastatic pheochromocytomas and paragangliomas: when and what
Sukrithan, V., Perez, K. J., Pandit-Taskar, N. D., & Jiménez, C. (2024) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2024.101116 · Cited by 32
Adrenal disease: a clinical update and overview of imaging. A review
Čtvrtlík, F., Koranda, P., & Tichý, T. (2014) · Biomedical Papers · doi:10.5507/bp.2014.010 · Cited by 32
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Zhang, W. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236094 · Cited by 30
“0 (Broad Institute) [19,20], the succinate dehydrogenase complex [21] inclusive of succinate dehydrogenase A [22], succinate dehydrogenase B [23], succinate dehydrogenase C [24], and succinate dehydrogenase D [25], as well as glycine decarboxylase [26–29] and glutaminase [30], is especially critical for tumorigenesis.”
BackgroundDifferential metabolic consequences of fumarate hydratase and respiratory chain defects
Raimundo, N., Ahtinen, J., Fumić, K., Barić, I., Remes, A. M., Renkonen, R., Lapatto, R., & Suomalainen, A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.008 · Cited by 32
Holt, D. E., Henthorn, P. S., Howell, V. M., Robinson, B. G., & Benn, D. E. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.03.007 · Cited by 29
Adrenal Medulla and Paraganglia
McNicol, A. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1069-1_12 · Cited by 34
The diagnostic value and functional roles of phosphoglycerate mutase 1 in glioma
Xu, Z., Gong, J., Wang, X., Wang, Y., Song, Y., Xu, W., Liu, Z., & Liu, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.5046 · Cited by 30
Pathophysiology of Hypertension
Yamaguchi, I., & Flynn, J. T. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_61 · Cited by 30
“In addition to the genes mentioned above, mutations of succinate dehydrogenase subunit genes (SDHB, SDHC, SDHD, SDHAF2, SDHA), a part of the mitochondrial complex, have been found [404–409].”
BackgroundLima, J. P., Teixeira-Gomes, J., Soares, P., Máximo, V., Honavar, M., Williams, E. D., & Sobrinho-Simões, M. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030008 · Cited by 30
Adrenal medulla and extra-adrenal paraganglia
Oudijk, L., de Krijger, R. R., Pacák, K., & Tischler, A. S. (2000) · Cited by 29
Pathophysiology and Diagnosis of Disorders of the Adrenal Medulla: Focus on Pheochromocytoma
Lenders, J. W. M., & Eisenhofer, G. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130034 · Cited by 32
Update on paragangliomas and pheochromocytomas
Lam, A. K.-Y. (2015) · Turkish Journal of Pathology · doi:10.5146/tjpath.2015.01318 · Cited by 28
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas
Mannelli, M., Canu, L., Ercolino, T., Rapizzi, E., Martinelli, S., Parenti, G., Filpo, G. D., & Nesi, G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0523 · Cited by 31
Liu, X., Qiao, Y., Ting, X., & Si, W. (2020) · PubMed · Cited by 38
Pheochromocytoma: Gasping for Air
Jochmanová, I., Zhuang, Z., & Pacák, K. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0231-4 · Cited by 30
Role of ultrasound and color Doppler imaging in the detection of carotid paragangliomas
Demattè, S., Sarra, D. D., Schiavi, F., Casadei, A., & Opocher, G. (2012) · Journal of Ultrasound · doi:10.1016/j.jus.2012.05.001 · Cited by 31
“Type 4 (PGL4): SDHB gene mutation [13]; 5.”
BackgroundPatócs, A., Karádi, É., Tóth, M., Varga, I., Szücs, N., Balogh, K., Majnik, J., Gláz, E., & Rácz, K. (2004) · European Journal of Cancer Prevention · doi:10.1097/00008469-200410000-00008 · Cited by 29
“Recently, germline mutations of the genes encoding for succinate dehydrogenase (SDH, mitochondrial complex II) subunits (SDHD, SDHB and SDHC) have been identified in patients with familial head and neck paragangliomas (Baysal et al., 2000; Niemann and Muller, 2000; Astuti et al., 2001) and SDHD and SDHB gene mutations…”
BackgroundInfluentialRapizzi, E., Ercolino, T., Canu, L., Giaché, V., Francalanci, M., Pratesi, C., Valeri, A., & Mannelli, M. (2012) · Endocrine Related Cancer · doi:10.1530/erc-11-0263 · Cited by 31
“…10.1530/ERC-11-0263 Online version via http://www.endocrinology-journals.org acid cycle (Baysal et al. 2000, Niemann &Müller 2000, Astuti et al. 2001, Burnichon et al. 2010) and in the mitochondrial electron transport chain, and the recently identified gene SDHAF2 (SDH5)…”
BackgroundMethodInfluentialJones, R. N., McDonald, K. E., Willson, J. A., Ghesquière, B., Sammut, D., Daniel, E., Harris, A. J., Lewis, A., Thompson, A. A. R., Dickinson, R. S., et al. (2016) · Blood · doi:10.1182/blood-2016-02-696922 · Cited by 31
“We questioned whether heterozygous germ line mutations in SDHB (SDHBx) would reduce SDH activity in the peripheral blood neutrophils of these patients, leading to accumulation of intracellular succinate, HIF-1a stabilization, and a pseudohypoxic survival phenotype, given the importance of the B subunit for SDH catalyt…”
BackgroundFunctional and in silico assessment of MAX variants of unknown significance
Comino‐Méndez, I., Leandro-Garcia, L. J., Montoya, G., Inglada‐Pérez, L., de Cubas, A. A., Currás-Freixes, M., Tysoe, C. J., Izatt, L., Letón, R., Gómez-Graña, Á., et al. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1306-y · Cited by 29
Berman, J. J. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-100 · Cited by 28
“Carotid body tumors (cervical paraganglioma), and multiple extra-adrenal pheochromocytomas [41,42] [OMIM record 115310]”
BackgroundLips, C. J. M., Lentjes, E. G. W. M., Höppener, J. W. M., van der Luijt, R. B., & Moll, F. L. (2006) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-4-4-169 · Cited by 30
“paragangliomas and in paragangliomas of the adrenal medulla [4].”
BackgroundMaier-Woelfle, M., Brändle, M., Komminoth, P., Saremaslani, P., Schmid, S., Locher, T., Heitz, P. U., Krull, I., Galeazzi, R. L., Schmid, C., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031236 · Cited by 28
“Although familial adrenal PCCs are caused by mutations of Ret (multiple endocrine neoplasia type 2, OMIM 164761), VHL (VHL, OMIM 193300), or NF1 (NF1, OMIM 162200), familial PGLs are caused by SDHD and rarely SDHC mutations (3–5), as well as by SDHB mutations (6).”
BackgroundTargeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy
Kruspig, B., Valter, K., Skender, B., Zhivotovsky, B., & Gogvadze, V. G. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.04.026 · Cited by 27
Lin, A., Anderson, S. L., Minard, K. I., & McAlister-Henn, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266890 · Cited by 30
Yao, L., Barontini, M., Niederle, B., Jech, M., Pfragner, R., & Dahia, P. L. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2245 · Cited by 27
Self-citationMolecular Genetic Alterations in Adrenal and Extra-Adrenal Pheochromocytomas and Paragangliomas
Dannenberg, H., Komminoth, P., Dinjens, W. N. M., Speel, E. M., & de Krijger, R. R. (2003) · Endocrine Pathology · doi:10.1385/ep:14:4:329 · Cited by 34
Cheng, V. W. T., Rothery, R. A., Bertero, M. G., Strynadka, N. C. J., & Weiner, J. H. (2005) · Biochemistry · doi:10.1021/bi050362p · Cited by 27
“Furthermore, mutation of this proline residue in human Complex II results in an autosomal dominant disease called hereditary paraganglioma ( 55 ).”
BackgroundQuality of life is decreased in patients with paragangliomas
van Hulsteijn, L. T., Louisse, A., Havekes, B., Kaptein, A. A., Jansen, J. C., Hes, F. J., Smit, J. W. A., & Corssmit, E. P. M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0968 · Cited by 28
Yamazaki, Y., Gao, X., Pecori, A., Nakamura, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Satoh, F., & Sasano, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.587769 · Cited by 36
“13 Germline PGL>PHEO Intermediate Famlilial PGL type 4 (14)”
BackgroundExon Junction Complex Mediates the Cap-Independent Translation of Circular RNA
Lin, H.-H., Chang, C.-Y., Huang, Y.-R., Shen, C., Wu, Y.-C., Chang, K.-L., Lee, Y., Lin, Y., Ting, W., Chien, H., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0877 · Cited by 26
Effects of octreotide therapy in progressive head and neck paragangliomas: Case series
van Hulsteijn, L. T., van Duinen, N., Verbist, B. M., Jansen, J. C., van der Klaauw, A. A., Smit, J. W. A., & Corssmit, E. P. M. (2013) · Head & Neck · doi:10.1002/hed.23348 · Cited by 26
“Genetic analysis had revealed a mutation in the succinate dehydrogenase subunit B gene, which is associated with familial paraganglioma.(30) The jugulotympanic tumor gave complaints of pulsatile tinnitus.”
BackgroundHavekes, B., van der Klaauw, A. A., Weiss, M. M., Jansen, J. C., van der Mey, A. G. L., Vriends, A. H. J. T., Bonsing, B. A., Romijn, J. A., & Corssmit, E. P. M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0024 · Cited by 27
“…in Great syndromes are associated with germ-line mutations in the genes encoding subunits of mitochondrial complex II succinate dehydrogenase (SDH): SDHD, SDHC, and SDHB (van der Mey et al. 1989, Baysal et al. 2000, Niemann & Muller 2000, Astuti et al. 2001, Koch et al. 2002, Benn & Robinson 2006).”
BackgroundMitochondrial Deficiencies in the Predisposition to Paraganglioma
Lussey‐Lepoutre, C., Buffet, A., Gimenez‐Roqueplo, A., & Favier, J. (2017) · Metabolites · doi:10.3390/metabo7020017 · Cited by 32
“In 2000, the description of the first mutations in the SDHD gene [14] in patients with PPGL was a major breakthrough, not only in the understanding of PPGL tumorigenesis but in cancer in general [14,15].”
BackgroundThe Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis
Nazar, E., Khatami, F., Saffar, H., & Tavangar, S. M. (2019) · International Journal of Hematology-Oncology and Stem Cell Research · doi:10.18502/ijhoscr.v13i2.692 · Cited by 37
The Occurrence of SDHB Gene Mutations in Pheochromocytoma
van Nederveen, F. H., Dinjens, W. N. M., Korpershoek, E., & de Krijger, R. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.018 · Cited by 26
Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx
Gimm, O. (2005) · Familial Cancer · doi:10.1007/s10689-004-5740-1 · Cited by 26
“Mutation analysis revealed mutations in both hereditary pheochromocytomas and paragangliomas [52].”
BackgroundCancer and the Kidney: The Growth of Onco-nephrology
Perazella, M. A., Berns, J. S., & Rosner, M. H. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.09.002 · Cited by 28
Tumour microenvironment in pheochromocytoma and paraganglioma
Martinelli, S., Amore, F., Canu, L., Maggi, M., & Rapizzi, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1137456 · Cited by 29
Paragangliomas of the head and neck
Kupferman, M. E., & Hanna, E. Y. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0024-9 · Cited by 29
High-Throughput Screening for Growth Inhibitors Using a Yeast Model of Familial Paraganglioma
Bancos, I., Bida, J. P., Tian, D., Bundrick, M., John, K., Holte, M. N., Her, Y. F., Evans, D. L., Saenz, D. T., Poeschla, E. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056827 · Cited by 26
“Five genes encoding subunits of the succinate dehydrogenase (SDH) complex (SdhA, SdhB, SdhC, and SdhD) [7–10] and the enzyme that flavinates SdhA [11,12] are the leading tumor suppressor genes in familial PGL.”
BackgroundMargetts, C. D. E., Morris, M. R., Astuti, D., Gentle, D., Cascón, A., McRonald, F. E., Catchpoole, D. R., Robledo, M., Neumann, H. P. H., Latif, F., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0072 · Cited by 30
“Thus, TSP1,CASP8,HIC1,DcR1,DcR2 andDR4 andRASSF1weremethylated frequently in both tumour types (Astuti et al. 2001c,Margetts et al. 2005).”
BackgroundSelf-citationEpigenetics of pheochromocytoma and paraganglioma
Björklund, P., & Backman, S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.016 · Cited by 40
Evenepoel, L., van Nederveen, F. H., Oudijk, L., Papathomas, T. G., Restuccia, D. F., Belt, E. J. T., de Herder, W. W., Feelders, R. A., Franssen, G. J. H., Hamoir, M., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01314 · Cited by 29
Albattal, S. B., Alswailem, M. M., Moria, Y., Al‐Hindi, H., Dasouki, M., Abouelhoda, M. I., Alkhail, H. A., AlSuhaibani, E. S., & Alzahrani, A. S. (2019) · Oncotarget · doi:10.18632/oncotarget.27194 · Cited by 27
Clinical and imaging overview of functional adrenal neoplasms
Low, G., & Sahi, K. (2012) · International Journal of Urology · doi:10.1111/j.1442-2042.2012.03014.x · Cited by 30
Clinical and Genetic Aspects of Phaeochromocytoma
Opocher, G., Schiavi, F., Conton, P., Scaroni, C. M., & Mantero, F. (2003) · Hormone Research in Paediatrics · doi:10.1159/000067846 · Cited by 30
“We evaluated the prevalence of SDHD mutations in a large sample of sporadic and non-syndromic cases of familial phaeochromocytoma but found no mutations of this gene.Recently, the gene coding for the B-subunit of the mitochondrial complex II, SDHB , has been found to be mutated in 3/5 familial and 1/24 sporadic cases…”
BackgroundDiagnosis and management of pheochromocytoma – recent advances and current concepts
Manger, W. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001974 · Cited by 32
Surgery of vagal paragangliomas: Six patients and review of literature
Lozano, F. S., Gómez, J. L., Mondillo, M. C., González‐Porras, J. R., González‐Sarmiento, R., & Muñoz, A. (2008) · Surgical Oncology · doi:10.1016/j.suronc.2008.03.001 · Cited by 28
SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas
Mhatre, A., Li, Y., Feng, L., Gasperin, A. C. H., & Lalwani, A. K. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00328.x · Cited by 31
Pheochromocytoma: implications in tumorigenesis and the actual management.
Shah, U. A., Giubellino, A., & Pacák, K. (2012) · PubMed · Cited by 30
Current Understanding of Mitochondrial DNA in Breast Cancer
Radpour, R., Fan, A. X., Kohler, C., Holzgreve, W., & Zhong, X. Y. (2009) · The Breast Journal · doi:10.1111/j.1524-4741.2009.00767.x · Cited by 25
Backman, S., Maharjan, R., Falk-Delgado, A., Crona, J., Cupisti, K., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2017) · Scientific Reports · doi:10.1038/srep44943 · Cited by 42
von Arx, C., Capozzi, M., López-Jiménez, E., Ottaiano, A., Tatangelo, F., Di Mauro, A., Nasti, G., Tornesello, M. L., & Tafuto, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091277 · Cited by 24
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas
Sarkadi, B., Meszaros, K., Krencz, I., Canu, L., Krokker, L., Zakarias, S., Barna, G., Sebestyen, A., Papay, J., Hujber, Z., et al. (2020) · Cancers · doi:10.3390/cancers12030599 · Cited by 23
Shiga, K., KATAGIRI, K., IKEDA, A., SAITO, D., Oikawa, S., Tsuchida, K., Miyaguchi, J., Kusaka, T., & Tamura, A. (2022) · Anticancer Research · doi:10.21873/anticanres.15522 · Cited by 23
Research progress on the pathogenesis of the SDHB mutation and related diseases
Liu, C., Zhou, D., Yang, K., Xu, N., Peng, J., & Zhu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115500 · Cited by 26
The role of mutation of metabolism-related genes in genomic hypermethylation
Waterfall, J. J., Killian, J. K., & Meltzer, P. S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.003 · Cited by 24
Genetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer
Piruat, J. I., & Millán‐Uclés, Á. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00200 · Cited by 23
“Soon after the identification of SDHD, mutations in SDHC and SDHB genes were found to be responsible for PGL3 and PGL4, respectively (18, 19).”
BackgroundLago, C. U., Nowinski, S. M., Rundhaug, J. E., Pfeiffer, M. E., Kiguchi, K., Hirasaka, K., Yang, X., Abramson, E. M., Bratton, S. B., Rho, O., et al. (2012) · Oncogene · doi:10.1038/onc.2011.630 · Cited by 25
Mitochondrial bioenergetics and disease in Caenorhabditis elegans
Rabbitts, B. M., Sedensky, M. M., & Morgan, P. G. (2015) · Frontiers in bioscience · doi:10.2741/4305 · Cited by 26
“This protein has an iron-sulphur center that mediates ubiquinone reduction and is mutated in human patients with paraganglioma and pheochromocytoma (123,124).”
BackgroundYang, J. H., Bae, S. J., Park, S., Park, H., Jung, H. S., Chung, J. H., Min, Y., Lee, M., Kim, K.-W., & Lee, M. (2007) · Endocrine Journal · doi:10.1507/endocrj.k06-068 · Cited by 23
“More recently nuclear genes encoding two mitochondrial complex II subunit proteins, SDHD and SDHB, have been associated with the development of familial pheochromocytomas and paragangliomas [7, 8].”
BackgroundLa génétique des paragangliomes et des phéochromocytomes
Favier, J., & Gimenez‐Roqueplo, A. (2012) · médecine/sciences · doi:10.1051/medsci/2012286016 · Cited by 29
“Après l’identification des gènes SDHD (succinate dehydrogenase complex, subunit D) [5], SDHC [6] et SDHB [7] dans les années 2000-2001, il apparut qu’au moins un quart des PGL/PCC étaient en fait héréditaires.”
BackgroundRecasens, M., Oriola, J., Fernández‐Real, J. M., Roig, J., Rodríguez‐Hermosa, J. I., Font, J. A., Galofré, P., López‐Bermejo, A., & Ricart, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02830.x · Cited by 25
Advances in paraganglioma–pheochromocytoma cell lines and xenografts
Bayley, J., & Devilee, P. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0434 · Cited by 26
SDHB variant type impacts phenotype and malignancy in pheochromocytoma-paraganglioma
Bayley, J., Bausch, B., Jansen, J. C., Hensen, E. F., van der Tuin, K., Corssmit, E. P. M., Devilee, P., & Neumann, H. P. H. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107656 · Cited by 24
Marzola, M. C., Chondrogiannis, S., Grassetto, G., Rampin, L., Maffione, A. M., Ferretti, A., Opocher, G., Schiavi, F., Colletti, P. M., & Rubello, D. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e31829aface · Cited by 23
Skonieczna, K., Malyarchuk, B. А., & Grzybowski, T. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.11.004 · Cited by 26
Mitochondrial dysfunction and risk of cancer
Lund, M., Melbye, M., Díaz, L. J., Dunø, M., Wohlfahrt, J., & Vissing, J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.66 · Cited by 22
“…syndrome, Hereditary Leiomyomatosis and Renal Cell Cancer (OMIM: 150800) (Kiuru et al, 2001; Launonen et al, 2001; Tomlinson et al, 2002), and mutations in the succinate dehydrogenase gene to predispose to various presentations of hereditary paragangliomas (Baysal et al, 2000; Astuti et al, 2001).”
Müller, U. (2011) · Neurogenetics · doi:10.1007/s10048-011-0280-y · Cited by 24
Smestad, J. A., Hamidi, O., Wang, L., Holte, M. N., Khazal, F. J. A., Erber, L. N., Chen, Y., & Maher, L. J. (2017) · Oncotarget · doi:10.18632/oncotarget.23639 · Cited by 21
Maher, M. J., Herath, A. S., Udagedara, S. R., Dougan, D. A., & Truscott, K. N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800195115 · Cited by 24
New Advances in the Genetics of Pheochromocytoma and Paraganglioma Syndromes
Gimenez‐Roqueplo, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.012 · Cited by 25
Palma, A. D., Lorusso, M., Gennaro, F. D., Quercia, R., Pizzuto, O., Garofalo, G., Fiorella, A., Maiolino, E., Nex, G., Schiavone, M., et al. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.09.01 · Cited by 24
“Mutations in the SDHB, SDHC and SDHD genes are clearly associated with an increased risk of paraganglioma (16,27-30).”
BackgroundFine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma
Opocher, G., Schiavi, F., Vettori, A., Pampinella, F., Vitiello, L., Calderan, A., Vianello, B., Murgia, A., Martella, M., Taccaliti, A., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01910.x · Cited by 25
Hereditary Paraganglioma Due to the SDHD M1I Mutation in a Second Chinese Family: A Founder Effect?
Lee, S. C., Chionh, S. B., Chong, S., & Taschner, P. E. M. (2003) · The Laryngoscope · doi:10.1097/00005537-200306000-00026 · Cited by 22
de Bresser, C. J. M., & de Krijger, R. R. (2024) · Endocrine Pathology · doi:10.1007/s12022-024-09830-3 · Cited by 29
Hussain, I., Husain, Q. M., Baredes, S., Eloy, J. A., Jyung, R. W., & Liu, J. K. (2013) · Journal of neurosurgery · doi:10.3171/2013.10.jns13659 · Cited by 22
Exploring the association of succinate dehydrogenase complex mutations with lymphoid malignancies
Renella, R., Carnevale, J. C., Schneider, K. A., Hornick, J. L., Rana, H. Q., & Janeway, K. A. (2014) · Familial Cancer · doi:10.1007/s10689-014-9725-4 · Cited by 23
A SDHB malignant paraganglioma with dramatic response to temozolomide–capecitabine
Nozières, C., Walter, T., Joly, M., Giraud, S., Scoazec, J., Borson‐Chazot, F., Simon, C., Riou, J. P., & Lombard‐Bohas, C. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1098 · Cited by 22
Mitochondrial metabolic remodeling in response to genetic and environmental perturbations
Hollinshead, K. E. R., & Tennant, D. A. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1334 · Cited by 24
Pediatric paraganglioma: An early manifestation of an adult disease secondary to germline mutations
Mora, J., Cascón, A., Robledo, M., & Català, A. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20680 · Cited by 21
McDonnell, C. M., Benn, D. E., Marsh, D. J., Robinson, B. G., & Zacharin, M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02122.x · Cited by 23
Cellular Respiration and Carcinogenesis
Sarangarajan, R., & Apte, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3 · Cited by 23
The clinical genetics of phaeochromocytoma and paraganglioma
Gunawardane, P. T. K., & Grossman, A. B. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000299 · Cited by 24
“Germline mutations of SDHB gene are inherited as autosomal dominant with the presence of sympathetic extra-adrenal paragangliomas, followed by adrenal phaeochromocytomas and parasympathetic head and neck paragangliomas (37,38).”
BackgroundAdvances in Adrenal and Extra-adrenal Paraganglioma: Practical Synopsis for Pathologists
Juhlin, C. C., & Mete, Ö. (2022) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000365 · Cited by 22
Proteomic and Mitochondrial Genomic Analyses of Pediatric Brain Tumors
Luna, B., Bhatia, S., Yoo, C., Felty, Q. H., Sandberg, D. I., DUCHOWNY, M. S., Khatib, Z. A., Miller, I., Ragheb, J. R., Prasanna, J., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8930-3 · Cited by 20
“However, research showing that inherited and sporadic cases of brain tumors (paraganglioma and pheochromocytoma) are caused by mutation of succinate dehydrogenase, a mitochondrial-specific protein of the Krebs cycle, provided support to the idea that mitochondria (mt) may control tumorigenesis [48].”
BackgroundNew genetic causes of pheochromocytoma: current concepts and the clinical relevance
Neumann, H. P. H., Cybulla, M., Shibata, H., Oya, M., Naruse, M., Higashihara, E., Terachi, T., Ling, H., Takami, H. E., Shuin, T., et al. (2005) · The Keio Journal of Medicine · doi:10.2302/kjm.54.15 · Cited by 23
Metadata
- Authors
- Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R.
- Affiliations
- University of Birmingham (GB)
- Dana-Farber Cancer Institute (US)
- Royal Victoria Infirmary (GB)
- Queen Elizabeth Hospital (GB)
- Uppsala University (SE)
- University of Cambridge (GB)
- Corresponding author
- Maher, Eamonn R.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 69
- Issue
- 1
- Pages
- 49-54
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1226047
- OpenAlex
- W2025719835
- Cited by
- 1,087
- References
- 28
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 18 · 2023: 31 · 2022: 29 · 2021: 40 · 2020: 29 · 2019: 51 · 2018: 42 · 2017: 47 · 2016: 54 · 2015: 46 · 2014: 70 · 2013: 61 · 2012: 75
- FWCI
- 37.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4401 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- British Heart Foundation
- National Cancer Institute (P-30-CA-16058, P30CA016058)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- succinate dehydrogenase, SDHB, SDHC, pheochromocytoma, paraganglioma, germline mutations, mitochondrial dysfunction, sporadic pheochromocytoma, tumor suppressor, RET proto-oncogene, VHL, neurofibromatosis type 1
- MeSH terms
- Proto-Oncogene Mas, Amino Acid Sequence, Base Sequence, DNA Mutational Analysis, Female, Haplotypes, Humans, Male, Molecular Sequence Data, Mutation, Paraganglioma, Pedigree, Pheochromocytoma, Succinate Dehydrogenase, Sequence Alignment, Germ-Line Mutation, Loss of Heterozygosity, Genetic Predisposition to Disease, Mutation, Missense, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.